AQR CAPITAL MANAGEMENT LLC

Position in ANNX — Annexon, Inc.

CIK 1167557 Greenwich, CT

Position in ANNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,305,977

+$408,919 QoQ

Shares Held

777,253

+0.1% QoQ

Ownership

0.389%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 92.74290353334113.ToString("F0")% Shared 0.ToString("F0")% None 7.2570964666588615.ToString("F0")%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. ANNX ranks #61 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,305,977	777,253	+0.1%	Shares	Other	2026-05-15
2025-12-31	$3,897,058	776,307	+35.2%	Shares	Defined	2026-02-17
2025-09-30	$1,751,073	574,123	+72.9%	Shares	Defined	2025-11-14
2025-06-30	$796,872	332,031	+350.0%	Shares	Other	2025-08-14
2025-03-31	$142,412	73,790	+122.6%	Shares	Other	2025-05-15
2024-12-31	$170,073	33,153	-48.8%	Shares	Other	2025-02-14
2024-09-30	$383,561	64,791	-76.8%	Shares	Defined	2024-11-14
2024-06-30	$1,369,367	279,463	+2356.2%	Shares	Defined	2024-08-14
2024-03-31	$81,579	11,378	-64.5%	Shares	Other	2024-05-15
2022-06-30	$120,719	32,021	-45.6%	Shares	Defined	2022-08-15
2022-03-31	$160,745	58,881	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.